Therapeutic strategies in liver cancer cells
| dc.contributor.advisor | Szabó, Zsuzsanna | |
| dc.contributor.advisor | Szabó, Erzsébet | |
| dc.contributor.advisor | Halmos, Gábor | |
| dc.contributor.advisordept | Debreceni Egyetem::Gyógyszerésztudományi Kar::Biofarmácia Tanszék | hu_HU |
| dc.contributor.author | Sepahizia, Sina | |
| dc.contributor.department | DE--Gyógyszerésztudományi Kar | hu_HU |
| dc.contributor.opponent | Zöld, Éva | |
| dc.contributor.opponent | Varga, István | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Fogorvostudományi Kar | hu_HU |
| dc.date.accessioned | 2019-05-30T04:40:25Z | |
| dc.date.available | 2019-05-30T04:40:25Z | |
| dc.date.created | 2019-03-04 | |
| dc.description.abstract | In present work, we also provide an overview of the biology of HCC, molecular mechanism of the disease, risk factors of HCC. We give the review of the most recent and future possible therapies of early and advanced stage of HCC. | hu_HU |
| dc.description.corrector | gj | |
| dc.description.course | gyógyszerész | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 40 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/268423 | |
| dc.language.iso | en | hu_HU |
| dc.subject | HCC | hu_HU |
| dc.subject | liver cancer | hu_HU |
| dc.subject | Hepatocellular Carcinoma | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Therapeutic strategies in liver cancer cells | hu_HU |